Table 3.
Mixed models all users
| (N = 837) | Score | 95% CI | p-value | N |
|---|---|---|---|---|
| PHQ-9 | ||||
| Pre-treatment | 10.37 | [9.96, 10.78] | – | – |
| Post-t change | −2.53 | [−3.00, − 2.06] | .000* | – |
| 19 week change | − 2.97 | [− 3.50, − 2.44] | .000* | – |
| Control | 0.00 | – | – | 419 |
| myCompass | 0.27 | [−0.30, 0.83] | .353 | 418 |
| GAD-7 | ||||
| Pre-treatment | 9.05 | [8.73, 9.39] | – | – |
| Post-t change | −2.03 | [−2.45, −1.62] | .000* | – |
| 19 week change | −2.10 | [−2.56, − 1.63] | .000* | – |
| Control | 0.00 | – | – | 419 |
| myCompass | 0.24 | [−0.20, 0.67] | .280 | 418 |
Note. PHQ-9 The Patient Health Questionnaire-9. GAD-7 The Generalized Anxiety Disorder 7-item scale